Showing results (1771-1780 of 2,335) with videos related to

Sort By:
Pageof 234
Inorganic Chemistry|June 13, 2014
Fluorescence in rhoda- and iridacyclopentadienes neglecting the spin-orbit coupling of the heavy atom: the ligand dominatesAndreas Steffen, Karine Costuas, Abdou Boucekkine, et al.
Cell Death and Differentiation|May 14, 2011
Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and functionL A Pasquini, V Millet, H C Hoyos, et al.
Community Mental Health Journal|July 27, 2010
Routine outcomes monitoring to support improving care for schizophrenia: report from the VA Mental Health QUERIAlexander S Young, Noosha Niv, Matthew Chinman, et al.
Neuroscience Letters|July 17, 2003
The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohortsLorraine N Clark, Gilberto Levy, Ming-Xin Tang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 15, 2013
Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutationAnat Mirelman, Talia Heman, Kira Yasinovsky, et al.
Annals of Neurology|June 1, 1997
Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13?K Wilhelmsen, D Mirel, K Marder, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 31, 2012
n-Doping of organic electronic materials using air-stable organometallics: a mechanistic study of reduction by dimeric sandwich compoundsSong Guo, Swagat K Mohapatra, Alexander Romanov, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 7, 2014
Dimers of nineteen-electron sandwich compounds: crystal and electronic structures, and comparison of reducing strengthsSwagat K Mohapatra, Alexandr Fonari, Chad Risko, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 31, 2018
Controllable, Wide-Ranging n-Doping and p-Doping of Monolayer Group 6 Transition-Metal Disulfides and DiselenidesSiyuan Zhang, Heather M Hill, Karttikay Moudgil, et al.
Neurology|November 4, 2009
Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohortE Y Uc, M P McDermott, K S Marder, et al.
Pageof 234